Northland raised the firm’s price target on Teradyne to $136 from $125 and keeps an Outperform rating on the shares. AI is increasing test capacity utilization and absorbing excess mobile test capacity and Teradyne is starting to benefit, says the analyst, who is increasing the firm’s 2024 and 2025 estimates based on higher semi test revenue.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TER: